- T20 -

Collaboration Progress Revolutionizing Rare Cancer Research through Teamwork and Innovation Donate Now Learn more about Our impact on rare cancer research through our partnership with the Broad Institute of MIT Harvard Rare Cancer Isnt Rare 25 OF CANCER PATIENTS ARE FACING A RARE CANCER THe challenge Patients with rare cancers face poor outcomes compared to patients with common cancers. This is because progress requires data and funding which is traditionally a challenge for rare disease research. Our Partnership with the Broad Institute of MIT Harvard is changing this. Our Approach Building a platform to accelerate the study and treatment of rare cancers in 4 steps See the Latest News and Updates Check out our latest updates from the Katie Moore Foundation and our partners The Broad Institute of MIT Harvard hosted their 2nd annual Rare Cancer Symposium with this years focus on the Rare Cancer Dependency Map Initiative.